1.OncoimmunologyT cells."11-0441 was used in Flow cytometry/Cell sorting to reveal a tumor-inhibiting role for LYG1 through promoting the activation, proliferation, and function of CD4+T cells in antitumor immune responses, offering implications for novel tumor immunotherapy."Authors Liu H,Zhang Y,Liu Z,Wang P,Mo X,Fu W,Liu W,Cheng Y,Han W2.The Journal of clinical investigationExcessive expression of miR-27 impairs Treg-mediated immunological tolerance.View published figure on By clicking the link above, you will be redirected to the Benchsci website. Disclaimer3.EBioMedicineStructure-guided development of a high-affinity human Programmed Cell Death-1: Implications for tumor immunotherapy."11-0441 was used in Flow cytometry/Cell sorting to highlight the value of structural considerations in the design of a PD-1 Ig fusion protein with immune modulatory properties."Authors Lázár-Molnár E,Scandiuzzi L,Basu I,Quinn T,Sylvestre E,Palmieri E,Ramagopal UA,Nathenson SG,Guha C,Almo SC4.Scientific reportsAn attenuated Mycobacterium tuberculosis clinical strain with a defect in ESX-1 secretion induces minimal host immune responses and pathology."11-0441 was used in Flow cytometry/Cell sorting to investigate the Mycobacterium tuberculosis (M.tb) DK9897 strain, showing that it is attenuated and has a defect in ESX-1 secretion, leading to minimal host immune response and pathology."Authors Clemmensen HS,Knudsen NPH,Rasmussen EM,Winkler J,Rosenkrands I,Ahmad A,Lillebaek T,Sherman DR,Andersen PL,Aagaard C5.The Journal of experimental medicineDC subset-specific induction of T cell responses upon antigen uptake via Fcγ receptors in vivo."11-0441 was used in Flow cytometry/Cell sorting to suggest that targeting antigens to FcγRs on DCs may be a promising approach to raise immunogenic or tolerogenic T cell responses to antigens of choice."Authors Lehmann CHK,Baranska A,Heidkamp GF,Heger L,Neubert K,Lühr JJ,Hoffmann A,Reimer KC,Brückner C,Beck S,Seeling M,Kießling M,Soulat D,Krug AB,Ravetch JV,Leusen JHW,Nimmerjahn F,Dudziak D |